Abbott Laboratories (ABT)CEO sold ~$20.9M

~$20.9M

Approx. value · 180K sh @ $116.19

306K

Holds after · shares reported

Traded

Aug 25, 2026

Filed

Aug 27, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed sale of ABT — reported range $15,001 - $50,000
2. Jun 12, 2026Congress · 1 personMembers of Congress: 2 purchases
3. Jun 16, 2026CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
4. Jul 2, 2026FDAFDA device clearance: Amplatzer TorqVue LP Delivery System; Amplatzer TorqVue LP Catheter
5. Jul 7, 2026Government · Federal Register proposed ruleMedicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots
6. Jul 8, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
7. Jul 14, 2026CongressDisclosed sale of ABT — reported range $15,001 - $50,000
8. Jul 15, 2026FDAFDA device clearance: EnSite™ X EP System
9. Jul 16, 2026Company filing · Form 8-K · ResultsReported its results
10. Jul 17, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
11. Jul 30, 2026CongressDisclosed sale of ABT — reported range $1,001 - $15,000
12. Aug 6, 2026Government · Federal Register noticeForeign-Trade Zone (FTZ) 39, Notification of Proposed Production Activity; Abbott Laboratories; (Diagnostic Medical Devices); Irving, Texas
13. Aug 11, 2026InsiderOfficer sold ~$643K of ABT shares in the open market
14. Aug 25, 2026 · this disclosureInsiderCEO sold ~$20.9M of ABT shares in the open market

What came next

1. Aug 25, 2026InsiderCEO sold ~$25.3M of ABT shares in the open market
2. Sep 2, 2026InsiderOfficer sold ~$3K of ABT shares in the open market
3. Sep 17, 2026FDAFDA device clearance: EnSite™ X EP System
4. Sep 23, 2026FDAFDA device clearance: Anti-HCV Next

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 82 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Robert B Ford, CHAIRMAN AND CEO

• SEC Form 4 at Abbott Laboratories (ABT)Aug 27, 2026
• SEC Form 4 at Abbott Laboratories (ABT)Jan 26, 2026
• SEC Form 4 at Abbott Laboratories (ABT)Feb 7, 2025

The full history of Robert B Ford, CHAIRMAN AND CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Abbott Laboratories

• SEC Form 4Sep 3, 2026
• SEC Form 144Sep 2, 2026
• SEC Form 4Aug 27, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 20, 2026
• House Clerk periodic transaction reportAug 18, 2026

Everything OQRO holds on this company is on its ABT page.